A latest report has been added to the wide database of Cardiovascular Implants Market by Infinium Global Research. This report studies the Cardiovascular Implants Market by drug class (disease modifying anti-rheumatic, nonsteroidal anti-inflammatory, corticosteroids, uric acid drugs), disease indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis)
A latest report has been added to the wide database of Cardiovascular Implants Market by Infinium Global Research. This report studies the Cardiovascular Implants Market by drug class (disease modifying anti-rheumatic, nonsteroidal anti-inflammatory, corticosteroids, uric acid drugs), disease indication (rheumatoid arthritis, osteoarthritis, gout, psoriatic arthritis, ankylosing spondylitis), distribution channel (hospital, retail, online pharmacy) market status and outlook of global and major regions, from manufacturers, and end industries. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. Cardiovascular Implants Market provides opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape, latest trends, and product offerings of the major companies in the Cardiovascular Implants Market. According to the report the Global Cardiovascular Implants Market is projected to grow at a CAGR of 6.1% in terms of value over the period of 2017-2023.
Get a Sample Request
CVDs includes coronary artery diseases (CAD) such as angina and myocardial infarction (heart attack). Other CVDs are peripheral arterial disease, stroke, heart failure, hypertensive heart disease, rheumatic heart disease, cardiomyopathy, heart arrhythmia, congenital heart disease, valvular heart disease, carditis, aortic aneurysms, peripheral artery disease, and venous thrombosis. There various treatment options available in the market to treat these cardiovascular diseases such as drug therapy (ACE inhibitors, antiarrhythmic, aspirin therapy, beta-blocker therapy, clot buster drugs, diuretics, etc.), changing lifestyle habits, and medical surgeries (stents, coronary stents, peripheral stents, heart bypass surgery, pacemakers, implantable cardioverter defibrillators, and heart transplants). These implants are lifesaving medium to improve the patient’s disease condition and are made of various materials, which includes metals, alloys, biomaterials, and polymers.
Some of the key driving factors attributing to the growth of this include increasing number of patients with cardiovascular diseases such as hypertension, heart failures and coronary artery diseases, and shortage of number of heart donors. In addition, changing lifestyle, alcohol consumption, growing obesity and smoking further propelling the market growth, as these factors increase the bold glucose and lipid levels, which results in serious cardiovascular diseases. According to American Heart Association publication, it has been estimated that in the US alone approximately 5.5 million people suffered from heart failure in 2013 and 300,000 die each year because of heart failure. The market for global cardiovascular implants was valued at USD 26.1 billion in 2015 and is expected to reach around USD 39.0 billion by 2023, growing at a CAGR of 5.8% during the forecast period of 2017 to 2023. However, there are certain restraining factors which could hamper the growth of the market, which includes, high-risk nature and high complication rates associated with considerable mortality, due to frequent use of implants in older populations with frequent co-morbidities. Geographically, North America is leading contributor to the market and is expected to retain its position during the forecast period. Nonetheless, the market for Asia-Pacific region is expected to grow at a faster rate owing to increasing prevalence of CVD diseases, growing awareness among the population, improving healthcare infrastructure, rise in healthcare spending, and favorable government policies.
Make an Enquiry
The report delivers a strategic analysis of the global market for cardiovascular implants and growth forecast for the period from 2017 – 2023. The scope of the report includes competitive analysis of various market players who are operating in the market, segmental analysis based on type of implants. It also covers geographical analysis of the market with growth forecast for the period of 2017 – 2023. The Porter’s Five Forces analysis and value chain analysis included in the report provides an insight into market dynamics and industry competition.
The study also provides information for recent merger and acquisition deals happened in the global cardiovascular implants market. Moreover, the report also includes growth strategies and entry barriers to be considered to cater to the exact business opportunities in this market. Additionally, to aid in strategic decision making, the report also includes competitive profiling of leading players, recent developments in the industry and various business strategies adopted by them. This report will help players in global cardiovascular implants market to plan and implement their strategies in different market areas such as emerging geographies, and new technologies.
Table of Contents:-
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches
2. Executive Summary
3. Global Cardiovascular Implants Market Overview
3.2. Market Dynamics
3.3. Porter's Five Forces Analysis
3.4. IGR-Growth Matrix Analysis
3.5. Competitive Landscape in the Global Cardiovascular Implants Market
4. Global Cardiovascular Implants Market by Type
4.1. Coronary Stents
4.2. Peripheral Stents
4.3. Heart Valves
4.4. Implanted Cardiac Pacemakers
4.5. Implantable Cardioverter Defibrillator
4.6. Cardiac Resynchronization Therapy (CRT) Device
5. Global Cardiovascular Implants Market by Region 2017-2023
5.1. North America
5.1.1. North America Cardiovascular Implants Market by Type
5.1.2. North America Cardiovascular Implants Market by Country
5.2.1. Europe Cardiovascular Implants Market by Type
5.2.2. Europe Cardiovascular Implants Market by Country
5.3.1. Asia-Pacific Cardiovascular Implants Market by Type
5.3.2. Asia-Pacific Cardiovascular Implants Market by Country
5.4.1. RoW Cardiovascular Implants Market by Type
5.4.2. RoW Cardiovascular Implants Market by Sub-region
6. Company Covered
6.1. Abbott Laboratories
6.3. Boston Scientific
6.4. Medtronic Plc.
6.5. St. Jude Medical, Inc.
6.6. C. R. Bard, Inc.
6.7. Cook Medical
6.8. Terumo Corporation
6.9. Edwards Lifesciences
6.10. AMG International
Click the Below Full Report Link